Adalimumab on Preventing Postoperative Recurrence of Crohn's Disease
Phase of Trial: Phase III
Latest Information Update: 08 Jan 2016
At a glance
- Drugs Adalimumab (Primary) ; Azathioprine; Metronidazole
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms APPRECIA
- 10 Jun 2017 Biomarkers information updated
- 16 Mar 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 13 Jan 2014 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.